A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Among 180 patients with moderate asthma, the specific aim of this randomized trial is to assess the effectiveness of an intervention involving education, enhancement of self-efficacy, and asthma social support in preventing deterioration in functional status over two years.
| Condition | Intervention |
|---|---|
|
Asthma |
Behavioral: Enhance asthma knowledge, self-efficacy, social support |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Single Blind (Subject) Primary Purpose: Health Services Research |
| Official Title: | A Randomized Trial to Improve Quality of Life Outcomes in Asthma Patients |
- The primary outcome is the change in the Asthma Quality of Life Questionnaire scores from enrollment to two years. [ Designated as safety issue: No ]
- The secondary outcomes are change in Asthma Self-efficacy Scale scores and differences in urgent resource utilization between groups. [ Designated as safety issue: No ]
| Enrollment: | 180 |
| Study Start Date: | August 2001 |
| Study Completion Date: | April 2005 |
| Primary Completion Date: | April 2005 (Final data collection date for primary outcome measure) |
The goals of this study are to develop and implement a multi-component intervention to improve quality of life and decrease urgent resource utilization in adult asthma patients followed in a primary care practice. Specifically, the intervention involves a two-component self-directed self-management workbook. The first component focuses on increasing knowledge by providing patients with factual information about asthma and self-management. The second component focuses on asthma self-efficacy using case vignettes and making a contract to adopt a behavior to improve asthma. Asthma-related social support is achieved through interval telephone contact.
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patients will be eligible for this study if they are 18 years of age or older and have moderate asthma based on the NHLBI Asthma Expert Panel's classification which rates symptoms, frequency of exacerbations, nocturnal attacks, activity restriction, use of medications, and pulmonary function.
Exclusion Criteria:
- Patients will be excluded from this study for the following reasons: if they are have other pulmonary diseases; if they are unable to provide informed consent because of cognitive deficits; if they are not fluent in English; if they refuse to participate.
Contacts and Locations| United States, New York | |
| New York Presbyterian Hospital - Weill Medical College of Cornell University | |
| New York, New York, United States, 10021 | |
| Principal Investigator: | Carol A Mancuso, MD | Hospital for Special Surgery, New York |
More Information
Publications:
Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
| Responsible Party: | Hospital for Special Surgery, New York |
| ClinicalTrials.gov Identifier: | NCT00197964 History of Changes |
| Other Study ID Numbers: | NHLBI K23 HL 04067 |
| Study First Received: | September 12, 2005 |
| Last Updated: | November 22, 2011 |
| Health Authority: | United States: Federal Government |
Keywords provided by Hospital for Special Surgery, New York:
|
Self-management Self-efficacy Quality of life Resource utilization |
Additional relevant MeSH terms:
|
Asthma Bronchial Diseases Respiratory Tract Diseases Lung Diseases, Obstructive Lung Diseases |
Respiratory Hypersensitivity Hypersensitivity, Immediate Hypersensitivity Immune System Diseases |
ClinicalTrials.gov processed this record on June 18, 2013